IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model

Hyeon Ju Ji, Mi La Cho, Young Mee Moon, Hye Joa Oh, Jin Sil Park, Joo Youn Jhun, So Youn Min, Young Gyu Cho, Kyung Su Park, Chong Hyeon Yoon, Jun Ki Min, Sung Hwan Park, Young Chul Sung, Ho Youn Kim

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

IL-23, a clinically novel cytokine, targets CD4+ T cells. Recent IL-1Ra-/- mouse studies have demonstrated that IL-23 indirectly stimulates the differentiation of osteoclast precursors by enhancing IL-17 release from CD4+ T cells. IL-17, in turn, stimulates osteoclastogenesis in osteoclast precursor cells. In this study, we found that IL-23 up-regulates receptor activator of NF-κB ligand expression by CD4+ T cells, and thus contributes to osteoclastogenesis. This indirect pathway is mediated by NF-κB and STAT3. We have also demonstrated that IL-23 can influence osteoclastogenesis positively under the special conditions in the IL-1-dominant milieu of IL-1Ra-/- mice. We propose that IL-23-enhanced osteoclastogenesis is mediated mainly by CD4+ T cells. The results of this study show that IL-23 is a promising therapeutic target for the treatment of arthritis-associated bone destruction.

Original languageEnglish (US)
Pages (from-to)1507-1518
Number of pages12
JournalJournal of Immunology
Volume181
Issue number2
StatePublished - Jul 15 2008

Fingerprint

Interleukin-23
Osteogenesis
Arthritis
Ligands
T-Lymphocytes
Interleukin 1 Receptor Antagonist Protein
Interleukin-17
Osteoclasts
Interleukin-1
Up-Regulation
Cytokines
Bone and Bones

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Ji, H. J., Cho, M. L., Moon, Y. M., Oh, H. J., Park, J. S., Jhun, J. Y., ... Kim, H. Y. (2008). IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. Journal of Immunology, 181(2), 1507-1518.

IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. / Ji, Hyeon Ju; Cho, Mi La; Moon, Young Mee; Oh, Hye Joa; Park, Jin Sil; Jhun, Joo Youn; Min, So Youn; Cho, Young Gyu; Park, Kyung Su; Yoon, Chong Hyeon; Min, Jun Ki; Park, Sung Hwan; Sung, Young Chul; Kim, Ho Youn.

In: Journal of Immunology, Vol. 181, No. 2, 15.07.2008, p. 1507-1518.

Research output: Contribution to journalArticle

Ji, HJ, Cho, ML, Moon, YM, Oh, HJ, Park, JS, Jhun, JY, Min, SY, Cho, YG, Park, KS, Yoon, CH, Min, JK, Park, SH, Sung, YC & Kim, HY 2008, 'IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model', Journal of Immunology, vol. 181, no. 2, pp. 1507-1518.
Ji, Hyeon Ju ; Cho, Mi La ; Moon, Young Mee ; Oh, Hye Joa ; Park, Jin Sil ; Jhun, Joo Youn ; Min, So Youn ; Cho, Young Gyu ; Park, Kyung Su ; Yoon, Chong Hyeon ; Min, Jun Ki ; Park, Sung Hwan ; Sung, Young Chul ; Kim, Ho Youn. / IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. In: Journal of Immunology. 2008 ; Vol. 181, No. 2. pp. 1507-1518.
@article{2c3383f1f2b64fe496466dd0131a152a,
title = "IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model",
abstract = "IL-23, a clinically novel cytokine, targets CD4+ T cells. Recent IL-1Ra-/- mouse studies have demonstrated that IL-23 indirectly stimulates the differentiation of osteoclast precursors by enhancing IL-17 release from CD4+ T cells. IL-17, in turn, stimulates osteoclastogenesis in osteoclast precursor cells. In this study, we found that IL-23 up-regulates receptor activator of NF-κB ligand expression by CD4+ T cells, and thus contributes to osteoclastogenesis. This indirect pathway is mediated by NF-κB and STAT3. We have also demonstrated that IL-23 can influence osteoclastogenesis positively under the special conditions in the IL-1-dominant milieu of IL-1Ra-/- mice. We propose that IL-23-enhanced osteoclastogenesis is mediated mainly by CD4+ T cells. The results of this study show that IL-23 is a promising therapeutic target for the treatment of arthritis-associated bone destruction.",
author = "Ji, {Hyeon Ju} and Cho, {Mi La} and Moon, {Young Mee} and Oh, {Hye Joa} and Park, {Jin Sil} and Jhun, {Joo Youn} and Min, {So Youn} and Cho, {Young Gyu} and Park, {Kyung Su} and Yoon, {Chong Hyeon} and Min, {Jun Ki} and Park, {Sung Hwan} and Sung, {Young Chul} and Kim, {Ho Youn}",
year = "2008",
month = "7",
day = "15",
language = "English (US)",
volume = "181",
pages = "1507--1518",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model

AU - Ji, Hyeon Ju

AU - Cho, Mi La

AU - Moon, Young Mee

AU - Oh, Hye Joa

AU - Park, Jin Sil

AU - Jhun, Joo Youn

AU - Min, So Youn

AU - Cho, Young Gyu

AU - Park, Kyung Su

AU - Yoon, Chong Hyeon

AU - Min, Jun Ki

AU - Park, Sung Hwan

AU - Sung, Young Chul

AU - Kim, Ho Youn

PY - 2008/7/15

Y1 - 2008/7/15

N2 - IL-23, a clinically novel cytokine, targets CD4+ T cells. Recent IL-1Ra-/- mouse studies have demonstrated that IL-23 indirectly stimulates the differentiation of osteoclast precursors by enhancing IL-17 release from CD4+ T cells. IL-17, in turn, stimulates osteoclastogenesis in osteoclast precursor cells. In this study, we found that IL-23 up-regulates receptor activator of NF-κB ligand expression by CD4+ T cells, and thus contributes to osteoclastogenesis. This indirect pathway is mediated by NF-κB and STAT3. We have also demonstrated that IL-23 can influence osteoclastogenesis positively under the special conditions in the IL-1-dominant milieu of IL-1Ra-/- mice. We propose that IL-23-enhanced osteoclastogenesis is mediated mainly by CD4+ T cells. The results of this study show that IL-23 is a promising therapeutic target for the treatment of arthritis-associated bone destruction.

AB - IL-23, a clinically novel cytokine, targets CD4+ T cells. Recent IL-1Ra-/- mouse studies have demonstrated that IL-23 indirectly stimulates the differentiation of osteoclast precursors by enhancing IL-17 release from CD4+ T cells. IL-17, in turn, stimulates osteoclastogenesis in osteoclast precursor cells. In this study, we found that IL-23 up-regulates receptor activator of NF-κB ligand expression by CD4+ T cells, and thus contributes to osteoclastogenesis. This indirect pathway is mediated by NF-κB and STAT3. We have also demonstrated that IL-23 can influence osteoclastogenesis positively under the special conditions in the IL-1-dominant milieu of IL-1Ra-/- mice. We propose that IL-23-enhanced osteoclastogenesis is mediated mainly by CD4+ T cells. The results of this study show that IL-23 is a promising therapeutic target for the treatment of arthritis-associated bone destruction.

UR - http://www.scopus.com/inward/record.url?scp=49049103008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49049103008&partnerID=8YFLogxK

M3 - Article

C2 - 18606706

AN - SCOPUS:49049103008

VL - 181

SP - 1507

EP - 1518

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -